Medrio, a provider of advanced eClinical software as a service (SaaS) for clinical research, has made key appointments to its board of directors: Richard H. Scheller, executive vice president of research at Genentech, and Dave Lipscomb, founder and former executive at NetSuite.

Scheller is responsible for setting the strategy for Genentech’s research and drug discovery activities, is a member of Genentech’s executive committee, and is a member of the Roche Enlarged Corporate Executive Committee. Prior to joining Genentech, he served as professor of molecular and cellular physiology at Stanford University and as an investigator with the Howard Hughes Medical Institute.

Lipscomb brings great depth in software as a service (SaaS) to Medrio after spending 14 years at NetSuite since its inception in 1998. Holding the titles senior vice president of engineering, chief information officer and senior vice president of customer loyalty, he drove engineering, product management and IT operations. Prior to joining NetSuite, Lipscomb founded mBED Software and was a director in Oracle’s New Media Division. He has been building client/server and web server software products for 20 years.